Literature DB >> 28677761

Expression and purification of a major allergen, Pla a 1, from Platanus acerifolia pollen and the preparation of its monoclonal antibody.

Wei-Wei Ni1, Wen Huang1, De-Qin Wu1, Yan-Jun Zhou1, Chun-Mei Ji1, Meng-Da Cao1, Miao Guo1, Jin-Lu Sun2, Ji-Fu Wei1.   

Abstract

Platanus acerifolia pollen is considered an important source of airborne allergens in numerous cities. Pla a 1 is a major allergen from P. acerifolia pollen. The present study aimed to express and purify Pla a 1, and to prepare its monoclonal antibody. In the present study, the Pla a 1 gene was subcloned into a pET‑28a vector and transformed into the ArcticExpress™ (DE3) RP Escherichia coli host strain. The purified Pla a 1 was then used to immunize BALB/c mice. When serum detection was positive, spleen cells were isolated from the mice and fused with SP2/0 myeloma cells at a ratio of 10:1. Hybridoma cells were screened by indirect ELISA and limiting dilution. Positive cells were used to induce the formation of antibody‑containing ascites fluid, and the antibodies were purified using protein A‑agarose. The results of the present study demonstrated that recombinant Pla a 1 was successfully expressed and purified, and exhibited positive immunoglobulin E‑binding to serum from patients allergic to P. acerifolia. A total of 11 hybridomas that steadily secreted anti‑Pla a 1 antibody were obtained and an immunoblotting analysis indicated that all of these monoclonal antibodies specifically recognized the Pla a 1 protein. These results suggested that specific anti‑Pla a 1 antibodies may be obtained, which can be used for the rapid detection of Pla a 1 allergens and in the preparation of vaccines against P. acerifolia pollen.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28677761     DOI: 10.3892/mmr.2017.6899

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  1 in total

Review 1.  Urban allergy review: Allergic rhinitis and asthma with plane tree sensitization (Review).

Authors:  Daniela Vrinceanu; Ovidiu Nicolae Berghi; Romica Cergan; Mihai Dumitru; Radu Constantin Ciuluvica; Calin Giurcaneanu; Adriana Neagos
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.